Literature DB >> 7035372

Immunization of mice by intracutaneous inoculation with viable virulent Cryptococcus neoformans: immunological and histopathological parameters.

S A Moser, F L Lyon, J E Domer, J E Williams.   

Abstract

Immune responses, including protection and delayed hypersensitivity, were evaluated in experimental murine cryptococcosis. Mice were immunized by the intracutaneous inoculation of viable virulent Cryptococcus neoformans yeasts. Response to the cutaneous infection was evaluated histologically and by cultural assays of the internal organs, as well as by intravenous challenge with the same strain. Protection was assessed by survival, histopathology, and quantitative organ culture. The intracutaneous inoculation of cryptococci resulted in a local inflammatory response that effectively limited dissemination of the organisms systemically and induced the development of delayed hypersensitivity demonstrable with a membrane extract of C. neoformans and with soluble cytoplasmic substances. A protective response was induced by the cutaneous inoculation of cryptococci as well, in that immunized animals survived longer, with about 25% of the challenged group ridding themselves completely of the cryptococci. Protection could be demonstrated by cultural analyses, but all animals, whether control or immunized, allowed considerable multiplication of the inoculum during the first 4 weeks after intravenous challenge. It would appear, therefore, that the protective mechanism(s) required additional antigenic stimulation before it could eventually function to eliminate all cryptococci from tissues. Histologically, there were no differences in pathology of the internal organs between immunized and unimmunized animals. Although the model described herein for the induction of immune responses in murine cryptococcosis has at least one drawback, viz., the presence of cryptococci in the skin lesion of many animals throughout the duration of the experiment, it does have the advantage that the immune responses were stimulated by a virulent strain and only minimal dissemination occurred. Therefore, lymphocytes could be removed from animals that were not contaminated with cryptococci for in vitro and in vivo transfer.

Entities:  

Mesh:

Year:  1982        PMID: 7035372      PMCID: PMC351096          DOI: 10.1128/iai.35.2.685-696.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Selective involvement of the brain in experimental murine cryptococcosis. II. Histopathological observations.

Authors:  G Grosse; S K Mishra; F Staib
Journal:  Zentralbl Bakteriol Orig A       Date:  1975-09

Review 2.  Pulmonary infection in the compromised host: part I.

Authors:  D M Williams; J A Krick; J S Remington
Journal:  Am Rev Respir Dis       Date:  1976-08

3.  Medium for selective isolation of Cryptococcus neoformans.

Authors:  A B Shields; L Ajello
Journal:  Science       Date:  1966-01-14       Impact factor: 47.728

4.  Experimental murine candidiasis: pathological and immune responses to cutaneous inoculation with Candida albicans.

Authors:  D K Giger; J E Domer; J T McQuitty
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

5.  Delayed-type hypersensitivity responses in infected mice elicited by cytoplasmic fractions of Cryptococcus neoformans.

Authors:  R J Hay; E Reiss
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

6.  Transfer of immunity to cryptococcosis by T-enriched splenic lymphocytes from Cryptococcus neoformans-sensitized mice.

Authors:  T S Lim; J W Murphy
Journal:  Infect Immun       Date:  1980-10       Impact factor: 3.441

7.  Host defense in cryptococcosis. III. Protection of nude mice by thymus transplantation.

Authors:  J R Graybill; L Mitchell; D J Drutz
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

8.  Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in mice.

Authors:  T S Lim; J W Murphy; L K Cauley
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

9.  Cyclophosphamide effects on murine cryptococcosis.

Authors:  J R Graybill; L Mitchell
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

10.  Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique.

Authors:  J W Murphy; G C Cozad
Journal:  Infect Immun       Date:  1972-06       Impact factor: 3.441

View more
  8 in total

1.  Non-specific immunosuppression in experimental cryptococcosis in rats.

Authors:  D T Masih; H R Rubinstein; C E Sotomayor; M E Ferro; C M Riera
Journal:  Mycopathologia       Date:  1986-05       Impact factor: 2.574

2.  Decreased resistance to primary intravenous Cryptococcus neoformans infection in aged mice despite adequate resistance to intravenous rechallenge.

Authors:  K M Aguirre; G W Gibson; L L Johnson
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

3.  Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice.

Authors:  M F Lipscomb; T Alvarellos; G B Toews; R Tompkins; Z Evans; G Koo; V Kumar
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

4.  L3T4(CD4)-, Lyt-2(CD8)- and Mac-1(CD11b)-phenotypic leukocytes in murine cryptococcal meningoencephalitis.

Authors:  P Dobrick; K Miksits; H Hahn
Journal:  Mycopathologia       Date:  1995-09       Impact factor: 2.574

5.  Cutaneous cryptococcosis in athymic and beige-athymic mice.

Authors:  C A Salkowski; E Balish
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

6.  Cellular immunity in a cutaneous model of cryptococcosis.

Authors:  J E Domer; F L Lyon; J W Murphy
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Genetic resistance to murine cryptococcosis: increased susceptibility in the CBA/N XID mutant strain of mice.

Authors:  G Marquis; S Montplaisir; M Pelletier; S Mousseau; P Auger
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

8.  Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.

Authors:  S Mukherjee; S Lee; J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.